BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 9040567)

  • 1. Lipid metabolism and APC: implications for colorectal cancer prevention.
    Watson AJ; Dubois RN
    Lancet; 1997 Feb; 349(9050):444-5. PubMed ID: 9040567
    [No Abstract]   [Full Text] [Related]  

  • 2. [Genetics of colon carcinogenesis].
    Sasaki S; Watanabe T; Nagawa H
    Nihon Rinsho; 2003 Sep; 61 Suppl 7():72-4. PubMed ID: 14574858
    [No Abstract]   [Full Text] [Related]  

  • 3. [The transgenic mouse model of familial polyposis coli].
    Fehmann HC; Eissele R
    Z Gastroenterol; 1997 Nov; 35(11):1035-7. PubMed ID: 9490555
    [No Abstract]   [Full Text] [Related]  

  • 4. [Colorectal cancer and inhibition of cyclooxygenase-2].
    Geissler M; Mohr L; Blum HE
    Dtsch Med Wochenschr; 2002 Jun; 127(23):1256-8. PubMed ID: 12053285
    [No Abstract]   [Full Text] [Related]  

  • 5. Cyclooxygenase inhibition in cancer--a blind alley or a new therapeutic reality?
    Chau I; Cunningham D
    N Engl J Med; 2002 Apr; 346(14):1085-7. PubMed ID: 11932478
    [No Abstract]   [Full Text] [Related]  

  • 6. Modulation of cyclooxygenase-2 expression by APC in HT-29 human colorectal carcinoma cells.
    Hsi LC; Angerman-Stewart J; Eling TE
    Adv Exp Med Biol; 2002; 507():127-31. PubMed ID: 12664576
    [No Abstract]   [Full Text] [Related]  

  • 7. [Familial adenomatous polyposis (FAP)--diagnosis and management].
    Gondo N; Nakagawa K; Yanagi H; Yamamura T
    Gan To Kagaku Ryoho; 2002 Apr; 29(4):532-8. PubMed ID: 11977536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of intestinal polyps in Msh2-deficient and non-Msh2-deficient multiple intestinal neoplasia mice by a specific cyclooxygenase-2 inhibitor and by a dual cyclooxygenase-1/2 inhibitor.
    Lal G; Ash C; Hay K; Redston M; Kwong E; Hancock B; Mak T; Kargman S; Evans JF; Gallinger S
    Cancer Res; 2001 Aug; 61(16):6131-6. PubMed ID: 11507063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The inducible prostaglandin biosynthetic enzyme, cyclooxygenase 2, is not mutated in patients with attenuated adenomatous polyposis coli.
    Spirio LN; Dixon DA; Robertson J; Robertson M; Barrows J; Traer E; Burt RW; Leppert MF; White R; Prescott SM
    Cancer Res; 1998 Nov; 58(21):4909-12. PubMed ID: 9809998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of polypogenesis in a new mouse strain with a truncated Apc(Delta474) by a novel COX-2 inhibitor, JTE-522.
    Sasai H; Masaki M; Wakitani K
    Carcinogenesis; 2000 May; 21(5):953-8. PubMed ID: 10783317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [From gene to disease; the APC gene and familial adenomatous polyposis coli].
    van der Luijt RB; Tops CM; Vasen HF
    Ned Tijdschr Geneeskd; 2000 Oct; 144(42):2007-9. PubMed ID: 11072519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cyclooxygenase 2 inhibitors and colorectal cancer].
    Bernardeau-Mozer M; Chaussade S
    Bull Cancer; 2004 May; 91 Spec No():S89-98. PubMed ID: 15239336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Intestinal polyposis in APC knockout mice: mechanism of tumorigenesis and chemotherapy].
    Taketo MM
    Seikagaku; 1999 Nov; 71(11):1299-308. PubMed ID: 10614178
    [No Abstract]   [Full Text] [Related]  

  • 14. Piroxicam-induced regression of intestinal adenomatous polyps in APC(delta474) mice.
    Qiu ZF; Maruyama K; Sunayama K; Kashiwabara H; Shoji T; Nakamura T; Suzuki S; Konno H; Nakamura S
    J Invest Surg; 2003; 16(2):71-81. PubMed ID: 12746190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations of the adenomatous polyposis coli gene in familial polyposis coli patients and sporadic colorectal tumors.
    Nakamura Y; Nishisho I; Kinzler KW; Vogelstein B; Miyoshi Y; Miki Y; Ando H; Horii A; Nagase H
    Princess Takamatsu Symp; 1991; 22():285-92. PubMed ID: 1668888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Rationale and prospects for the use of cyclooxygenase-2 (COX-2) inhibitors in colorectal cancer].
    Buecher B; Heymann MF; Blottière HM
    Gastroenterol Clin Biol; 2001 Nov; 25(11):967-78. PubMed ID: 11845047
    [No Abstract]   [Full Text] [Related]  

  • 17. Aspirin use and potential mechanisms for colorectal cancer prevention.
    Williams CS; Smalley W; DuBois RN
    J Clin Invest; 1997 Sep; 100(6):1325-9. PubMed ID: 9294096
    [No Abstract]   [Full Text] [Related]  

  • 18. Somatic instability of the APC I1307K allele in colorectal neoplasia.
    Gryfe R; Di Nicola N; Gallinger S; Redston M
    Cancer Res; 1998 Sep; 58(18):4040-3. PubMed ID: 9751605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cyclooxygenase 2 inhibitors and adenomatous polyposis coli].
    Florent C; Meary N
    Bull Cancer; 2004 May; 91 Spec No():S85-8. PubMed ID: 15239335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Familial polyposis: recent advances.
    Miyaki M; Tanaka K; Kikuchi-Yanoshita R; Muraoka M; Konishi M
    Crit Rev Oncol Hematol; 1995 Apr; 19(1):1-31. PubMed ID: 7741978
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.